Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06163482 · ClinicalTrials.gov registry record · Early Phase 1
Hormonal Responses to a Mixed Meal in People With Cystic Fibrosis
A Early Phase 1 study of Cystic Fibrosis, sponsored by University of Cincinnati.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 61
- Enrollment target
- 1
- Study location
NCT06163482: Recruiting Early Phase 1 study of Cystic Fibrosis, sponsored by University of Cincinnati.
NCT06163482 is a Early Phase 1 study of Cystic Fibrosis that is actively recruiting participants, run by University of Cincinnati. The registered enrollment target is 61 participants, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06163482, a Early Phase 1 study of Cystic Fibrosis, is actively recruiting participants, sponsored by University of Cincinnati.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 61 participants
- Enrollment target
- 1
- Study location
Study Summary
In this exploratory study, the hormonal responses to a mixed meal will be examined in people with cystic fibrosis. The aim of this study is to find correlates with impaired glucose tolerance that is associated with this population.
Primary Outcome
human plasma
Conditions Studied
Interventions
- OTHER Mixed meal
Study Locations (1)
Ohio
- University of Cincinnati - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2023-03-28 |
| Est. Completion | 2026-12-30 |
| Phase | Early Phase 1 |
What NCT06163482 shows while recruiting
NCT06163482 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Cystic Fibrosis appearing as the primary indexed condition, and to 1 intervention - of which Mixed meal is the first listed.
NCT06163482 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06163482 about?
NCT06163482 is a clinical study titled "Hormonal Responses to a Mixed Meal in People With Cystic Fibrosis". In this exploratory study, the hormonal responses to a mixed meal will be examined in people with cystic fibrosis. The aim of this study is to find correlates with impaired glucose tolerance that is associated with this population.
What is the current status of trial NCT06163482?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 61 participants. The study started on 2023-03-28. Estimated completion is 2026-12-30.
What conditions does trial NCT06163482 study?
This clinical trial studies the following conditions: Cystic Fibrosis.
What interventions are being tested in trial NCT06163482?
The interventions under investigation include: Mixed meal (OTHER).
Who is sponsoring clinical trial NCT06163482?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06163482 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06163482's enrollment target sits among peer trials
61 81st of 169 higher than 89 of 169 other Cystic Fibrosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cystic Fibrosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Regional Monitoring of CF Lung Disease
RECRUITING · Early Phase 1
-
Personalized Theratyping Trial
RECRUITING · Early Phase 1
-
Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240
ACTIVE NOT RECRUITING · Early Phase 1
-
19F MRI to Evaluate Regional Ventilation in Healthy Subjects and Subjects With Cystic Fibrosis
COMPLETED · Early Phase 1
-
Exercise in Child Health
RECRUITING · NA
-
Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI